SavedAdd your journal

Journals / Acta Medica Nicomedia / 2025 / Cilt: 8 Sayı: 3

Prognostic Significance of Histopathological and Hematological Markers in Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tümörlerde Histopatolojik ve Hematolojik Belirteçlerin Prognostik Rolü

Adem Şentürk(Sakarya Training and Research Hospital)0000-0002-7626-4649
Emre Gönüllü(SAKARYA ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-6391-4414
Alp Ömer Cantürk(Sakarya Training and Research Hospital)0000-0003-3641-7628
Ahmet Tarık Harmantepe(SAKARYA ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-2888-7646
Recayi Capoglu(Sakarya Training and Research Hospital)0000-0003-4438-4301
Fuldem Mutlu(SAKARYA ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-7761-2417
Pages
287–294
Publication Date
2025-10-22
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Abstract Objective: This study aimed to evaluate the relationship between overall survival and preoperative systemic inflammation and nutritional indices in patients with gastrointestinal stromal tumors (GIST), in addition to conventional histopathological parameters.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract Objective: This study aimed to evaluate the relationship between overall survival and preoperative systemic inflammation and nutritional indices in patients with gastrointestinal stromal tumors (GIST), in addition to conventional histopathological parameters.
📊
Key Findings & Data:Methods: In this retrospective study, 43 patients who underwent surgery for GIST were analyzed.
💡
Conclusion & Impact:However, further large-scale prospective studies are warranted to validate these findings.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:GIST · sistemik inflamasyon · sağkalım

Abstract

Abstract Objective: This study aimed to evaluate the relationship between overall survival and preoperative systemic inflammation and nutritional indices in patients with gastrointestinal stromal tumors (GIST), in addition to conventional histopathological parameters. Methods: In this retrospective study, 43 patients who underwent surgery for GIST were analyzed. Demographic, laboratory, and pathological data were reviewed. Inflammatory and nutritional indices—including HALP, NLR, SII, PNI, and CRP/Albumin—were calculated from preoperative blood parameters. Their effects on 3-year survival were assessed using the Kaplan-Meier method and the log-rank test. Results: High mitotic count and Ki67 index were significantly associated with decreased survival. Patients with elevated RDW levels had significantly shorter survival times (p<0.05). Classification accuracy for HALP, NLR, SII, PNI, and CRP/Albumin was found to be moderate based on their respective cut-off values. Conclusion: This study demonstrates that, in addition to histopathological markers, systemic inflammatory and nutritional indices may serve as useful prognostic tools in GIST patients. These indices could aid in the development of individualized follow-up strategies postoperatively. However, further large-scale prospective studies are warranted to validate these findings.

Özet

Giriş: Bu çalışmada, gastrointestinal stromal tümör (GIST) tanısı almış ve cerrahi tedavi uygulanmış hastalarda, klasik histopatolojik parametrelerin yanı sıra preoperatif dönemde elde edilen sistemik inflamasyon ve beslenme indekslerinin sağkalım ile ilişkisi değerlendirildi. Gereç ve Yöntem:Retrospektif olarak tasarlanan bu çalışmaya, GIST tanısı ile cerrahi uygulanmış 43 hasta dahil edildi. Hastaların demografik, laboratuvar ve patolojik verileri incelendi. Hematolojik parametrelerden hesaplanan HALP, NLR, SII, PNI ve CRP/Alb gibi indekslerin 3 yıllık sağkalım üzerindeki etkileri Kaplan-Meier yöntemi ve log-rank testi ile değerlendirildi. Bulgular:Yüksek mitoz sayısı ve Ki67 proliferasyon indeksi, sağkalımı olumsuz etkileyen anlamlı histopatolojik faktörler olarak belirlendi. RDW düzeyi yüksek olan hastalarda sağkalım süresi anlamlı şekilde daha kısaydı (p<0.05). HALP, SII, NLR, PNI ve CRP/Alb oranı gibi kompozit indekslerin cut-off değerlerine göre sınıflandırma doğruluğu orta düzeydeydi. Sonuç: Bu çalışma, GIST hastalarında yalnızca histopatolojik değil, aynı zamanda sistemik inflamasyon ve beslenme durumunu yansıtan biyobelirteçlerin de sağkalım öngörüsünde kullanılabileceğini ortaya koymuştur. Bu indeksler, postoperatif dönemde bireyselleştirilmiş takip stratejilerine katkı sağlayabilir; ancak bu sonuçların doğrulanması için daha geniş ve prospektif çalışmalara ihtiyaç vardır.

🔖

Cite This Article

Şentürk, A., Gönüllü, E., Cantürk, A. Ö., Harmantepe, A. T., Capoglu, R., Mutlu, F. (2025). Prognostic Significance of Histopathological and Hematological Markers in Gastrointestinal Stromal Tumors. Acta Medica Nicomedia, Cilt: 8 Sayı: 3, 287–294. https://doi.org/10.53446/actamednicomedia.1677338

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (22)

  1. Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466-1478. doi:10.5858/2006-130-1466-GSTROM.
  2. Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39-46. doi:10.1016/j.canep.2015.10.031.
  3. Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382(9896):973-983. doi:10.1016/S0140-6736(13)60106-3.
  4. Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 2009;10(11):1045-1052. doi:10.1016/S1470-2045(09)70242-6.
  5. Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol. 2012;33(3):749-756. doi:10.1007/s13277-011-0285-z.
  6. Sun YF, Cao XK, Wei Q, Gao YH. Potential biomarkers for the prognosis of gastrointestinal stromal tumors. World J Gastrointest Oncol. 2025;17(4):1028-1031. doi:10.4251/wjgo.v17.i4.102831.
  7. Capoglu R, Bayhan Z, Gönüllü E, Coskun M, Harmantepe AT, Kucuk F, et al. Malign tiroid nodülleri için biyolojik belirteçlerin prediktif değeri: tek merkez deneyimi. J Biotechnol Strateg Health Res. 2022;6:188-195.
  8. Gönüllü E, Kucuk F, Bayhan Z, Harmantepe AT, Capoglu R. Akut kolesistitte kolesistektomi veya kolesistostomi yapılması gerekecek hastaların ayırt edilmesinde biyolojik indeksler. Sak Med J. 2022;6(3):489 - 495. doi:10.31832/smj.1094111.
  9. Wang T, Qi L, Zhao Y, Ma X, Li T. Inflammatory biomarker correlations and prognosis in high-risk gastrointestinal stromal tumor patients: a multicenter retrospective analysis. BMC Gastroenterol. 2025;25:119. doi:10.1186/s12876-025-03710-8.
  10. Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265-274. doi:10.1016/S1470-2045(11)70299-6.
  11. DeMatteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer. 2008;112(3):608-615. doi:10.1002/cncr.23199.
  12. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-899. doi:10.1016/j.cell.2010.01.025.
  13. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-444. doi:10.1038/nature07205.
  14. Bongers BC, Dejong CHC, den Dulk M. Enhanced recovery after surgery programmes in older patients undergoing hepatopancreatobiliary surgery: what benefits might prehabilitation have? Eur J Surg Oncol. 2021;47(3):551-559. doi:10.1016/j.ejso.2020.10.030.
  15. Cuzick J, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Ho L, et al. Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer. 2013;108(4):908-913. doi:10.1038/bjc.2013.48.
  16. Duzkopru Y, Kocanoglu A, Dogan O, Sahinli H, Cilbir E, Altinbas M. Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer. World J Gastrointest Oncol. 2023;15(9):1626-1635. doi:10.4251/wjgo.v15.i9.1626.
  17. Lolli C, Caffo O, Scarpi E, Aieta M, Conteduca V, Maines F, et al. Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic castration-resistant prostate cancer treated with abiraterone. Front Pharmacol. 2016;7:376. doi:10.3389/fphar.2016.00376.
  18. Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, et al. Systemic immune-inflammation index (SII) predicts poor survival in pancreatic cancer patients undergoing resection. J Gastrointest Surg. 2020;24(3):610-618. doi:10.1007/s11605-019-04487-2.
  19. Jiang N, Deng JY, Ding XW, Ke B, Liu N, Zhang RP, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol. 2014;20(30):10537-10544. doi:10.3748/wjg.v20.i30.10537.
  20. Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer. 2009;100(2):412-420. doi:10.1038/sj.bjc.6604820.
  21. Hashimoto S, Tominaga T, Nonaka T, Hamada K, Araki M, Takeshita H, et al. The C-reactive protein to albumin ratio predicts postoperative complications in oldest-old patients with colorectal cancer. Int J Colorectal Dis. 2020;35(3):423-431. doi:10.1007/s00384-019-03458-7.
  22. Koma Y, Onishi A, Matsuoka H, Oda N, Yokota N, Matsumoto Y, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One. 2013;8(11):e80240. doi:10.1371/journal.pone.0080240.